Komipharm is trading at 18,350 KRW as of 10:31 AM on the 12th, up 0.27% from the previous day. This is a decline of 11.57% compared to May 15. Komipharm is known as a producer of veterinary vaccines and disinfectants.

Today, foreigners have tentatively net purchased 22,712 shares of Komipharm, and institutions have net purchased 2,000 shares. Over the past five days, individual investors have net purchased 67,970 shares, while foreigners and institutions have net sold 24,156 shares and 33,254 shares, respectively.

On June 8, Komipharm was a market issue due to "weakness following the Ministry of Food and Drug Safety’s rejection of the COVID-19 treatment clinical trial."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing